1. Estimate 40 units delivered/on order by Q1/2013. 2. Estimate FDA and EPA approval 1/2013. 3. Approved for sale/use in Canada and New Zealand. 4. Estimate E.U. approval early 2013. 5. An earlier message discussed serious interest by more than one major distributor.
Would any major US distributor be seriously interested in a product with no US patent protection, no FDA/EPA approval, no US hospital testing and no current manufacturing capability?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.